Systemic Chemotherapy

Treatment with anticancer drugs that travel through the blood to cells all over the body.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in…
BACKGROUND Patients with peritoneal metastatic colorectal cancer have reduced overall survival compared with patients with… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.
PURPOSE Symptoms and complications of metastatic colorectal cancer (mCRC) differ by metastatic sites. There is a paucity of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
PURPOSE Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
The treatment of peritoneal carcinomatosis is based on cytoreduction followed by hyperthermic intraperitoneal chemotherapy and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2008
Review
2008
Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.
Systemic therapy improves the survival and quality of life of patients with advanced stage non-small cell lung cancer (NSCLC… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.
PURPOSE Dysfunctional tumor vessels can be a significant barrier to effective cancer therapy. However, increasing evidence… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.
OBJECTIVE : To assess the effects of preoperative systemic chemotherapy on remnant liver parenchyma, liver function, and… (More)
  • table 2
  • table 1
  • table 4
  • table 3
  • figure 1
Is this relevant?
Review
2005
Review
2005
Chemotherapy for advanced gastric cancer.
BACKGROUND Gastric cancer currently ranks second in global cancer mortality. Most patients are either diagnosed at an advanced… (More)
Is this relevant?
Review
2005
Review
2005
WHO-EORTC classification for cutaneous lymphomas.
Primary cutaneous lymphomas are currently classified by the European Organization for Research and Treatment of Cancer (EORTC… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
BACKGROUND In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemic treatment to surgery might… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?